Activity ID
11935Expires
May 17, 2024Format Type
LiveCME Credit
1Fee
$0CME Provider: Clinical Care Options, LLC
Description of CME Course
The goal of this program is to improve the knowledge and competence of learners to optimize treatment for patients with ADAD.
ABMS Member Board Approvals by Type
ABMS Lifelong Learning CME Activity
Family Medicine
Psychiatry and Neurology
Commercial Support?
NoNOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Educational Objectives
• Identify the hypothesized mechanism of disease in ADAD, including neurotransmitter and brain region involvement
• Recognize the mechanisms of action for new and emerging treatment options for ADAD
• Assess the latest clinical evidence for new and emerging options for the treatment of ADAD
Keywords
Alzheimer's Disease COVID-19
Competencies
Medical Knowledge
CME Credit Type
AMA PRA Category 1 Credit
Practice Setting
Academic Medicine, Inpatient, Outpatient, Rural, Urban, VA/Military
